Skip to main content
Clinical Trials/IRCT20180203038600N1
IRCT20180203038600N1
Completed
Phase 2

A randomized clinical trial for comparison of two methods of BOTOX injection (FTP & FSFD) to improve headache frequency & quality of life of migrainous headache patients

Rafsanjan University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
chronic migraine.
Sponsor
Rafsanjan University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who have at least 15 days headache that maintain for 4 hour or more
  • Patients who had no improvement in severity \& frequency of headaches by using prophylactic drug agents like that Beta blockers, CCB, anti convulsive drugs \& anti depressant

Exclusion Criteria

  • History of BOTOX injection or other Botulinum serotypes
  • Neuromuscular junction disease
  • Psychologic disorders that have negative impact on clinical trial
  • Beck severity scale of depression more than 24
  • Primary or secondary headaches due to another reasons
  • Complicated migraine
  • Drug sensivity
  • Coagulopathy
  • Infection of injection skin site

Outcomes

Primary Outcomes

Not specified

Similar Trials